Omnicell Shares Rise on Revised Guidance Following Reduced Tariffs

Dow Jones

2025/05/22

By Denny Jacob

Omnicell shares rose 5.8% after the company updated its guidance following a temporary reduction in tariffs on China.

Shares were trading around $28.93. The stock is down around 35% on the year.

The healthcare technology company, which automates medication management for hospitals and pharmacies, said it now expects adjusted earnings per-share in the range of 24 cents and 34 cents in the second quarter. It previously forecast adjusted earnings per-share between 19 cents and 32 cents.

For 2025, adjusted earnings are forecast to come in between $1.30 a share and $1.65 a share. It previously forecast adjusted earnings per-share between $1 and $1.65.

Omnicell also disclosed its board approved a new $75 million stock repurchase program, adding to the buyback program approved in 2016 allowing for the repurchase of up to $50 million of the company's common stock.

Chief Executive Randall Lipps said the Trump administration's recent reduction in tariffs on China compelled the company to update its guidance to reflect "the expected diminished impact on our supply chain and anticipated improved profitability."

Write to Denny Jacob at denny.jacob@wsj.com

(END) Dow Jones Newswires

May 22, 2025 11:17 ET (15:17 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2537928553"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2537928553\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2537928553?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-22 23:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2537928553","market":"sg","top_or_hot":-1,"title":"Omnicell Shares Rise on Revised Guidance Following Reduced Tariffs","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Denny Jacob \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> shares rose 5.8% after the company updated its guidance following a temporary reduction in tariffs on China. \n</p>\n<p>\n  Shares were trading around $28.93. The stock is down around 35% on the year. \n</p>\n<p>\n  The healthcare technology company, which automates medication management for hospitals and pharmacies, said it now expects adjusted earnings per-share in the range of 24 cents and 34 cents in the second quarter. It previously forecast adjusted earnings per-share between 19 cents and 32 cents. \n</p>\n<p>\n  For 2025, adjusted earnings are forecast to come in between $1.30 a share and $1.65 a share. It previously forecast adjusted earnings per-share between $1 and $1.65. \n</p>\n<p>\n  Omnicell also disclosed its board approved a new $75 million stock repurchase program, adding to the buyback program approved in 2016 allowing for the repurchase of up to $50 million of the company's common stock. \n</p>\n<p>\n  Chief Executive Randall Lipps said the Trump administration's recent reduction in tariffs on China compelled the company to update its guidance to reflect \"the expected diminished impact on our supply chain and anticipated improved profitability.\" \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Denny Jacob at denny.jacob@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 22, 2025 11:17 ET (15:17 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Omnicell Shares Rise on Revised Guidance Following Reduced Tariffs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOmnicell Shares Rise on Revised Guidance Following Reduced Tariffs\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-05-22 23:17</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Denny Jacob \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> shares rose 5.8% after the company updated its guidance following a temporary reduction in tariffs on China. \n</p>\n<p>\n  Shares were trading around $28.93. The stock is down around 35% on the year. \n</p>\n<p>\n  The healthcare technology company, which automates medication management for hospitals and pharmacies, said it now expects adjusted earnings per-share in the range of 24 cents and 34 cents in the second quarter. It previously forecast adjusted earnings per-share between 19 cents and 32 cents. \n</p>\n<p>\n  For 2025, adjusted earnings are forecast to come in between $1.30 a share and $1.65 a share. It previously forecast adjusted earnings per-share between $1 and $1.65. \n</p>\n<p>\n  Omnicell also disclosed its board approved a new $75 million stock repurchase program, adding to the buyback program approved in 2016 allowing for the repurchase of up to $50 million of the company's common stock. \n</p>\n<p>\n  Chief Executive Randall Lipps said the Trump administration's recent reduction in tariffs on China compelled the company to update its guidance to reflect \"the expected diminished impact on our supply chain and anticipated improved profitability.\" \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Denny Jacob at denny.jacob@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 22, 2025 11:17 ET (15:17 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4167","symbol_name":"醫療保健技術","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2537928553","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2537928553","pubTimestamp":1747927020,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Omnicell shares rose 5.8% after the company updated its guidance following a temporary reduction in tariffs on China.Shares were trading around $28.93. The stock is down around 35% on the year.The healthcare technology company, which automates medication management for hospitals and pharmacies, said it now expects adjusted earnings per-share in the range of 24 cents and 34 cents in the second quarter. It previously forecast adjusted earnings per-share between 19 cents and 32 cents.For 2025, adjusted earnings are forecast to come in between $1.30 a share and $1.65 a share. It previously forecast adjusted earnings per-share between $1 and $1.65.Omnicell also disclosed its board approved a new $75 million stock repurchase program, adding to the buyback program approved in 2016 allowing for the repurchase of up to $50 million of the company's common stock.Chief Executive Randall Lipps said the Trump administration's recent reduction in tariffs on China compelled the company to update its g","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4167":"医疗保健技术","OMCL":"Omnicell","BK4082":"医疗保健设备"},"translate_title":"Omnicell股价因关税降低后修订指引而上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OMCL":1},"content_text":"By Denny Jacob \n\n\n \n\n\nOmnicell shares rose 5.8% after the company updated its guidance following a temporary reduction in tariffs on China. \n\n\n  Shares were trading around $28.93. The stock is down around 35% on the year. \n\n\n  The healthcare technology company, which automates medication management for hospitals and pharmacies, said it now expects adjusted earnings per-share in the range of 24 cents and 34 cents in the second quarter. It previously forecast adjusted earnings per-share between 19 cents and 32 cents. \n\n\n  For 2025, adjusted earnings are forecast to come in between $1.30 a share and $1.65 a share. It previously forecast adjusted earnings per-share between $1 and $1.65. \n\n\n  Omnicell also disclosed its board approved a new $75 million stock repurchase program, adding to the buyback program approved in 2016 allowing for the repurchase of up to $50 million of the company's common stock. \n\n\n  Chief Executive Randall Lipps said the Trump administration's recent reduction in tariffs on China compelled the company to update its guidance to reflect \"the expected diminished impact on our supply chain and anticipated improved profitability.\" \n\n\n \n\n\n  Write to Denny Jacob at denny.jacob@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 22, 2025 11:17 ET (15:17 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}